Design and synthesis of sodium (βR*,γS*)-4-[[3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)pro pyl[thio]-γ-hydroxy-β-methylbenzenebutanoate: A novel, selective, and orally active receptor antagonist of leukotriene D4

DOI: 10.1021/jm00159a003

Source and publish data:

Journal of Medicinal Chemistry p. 1573 - 1576 (1986)

Update date:2022-07-29

Topics:

Authors:

Young

Belanger

Champion

DeHaven

Denis

Ford-Hutchinson

Fortin

Frenette

Gauthier

Gillard